Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience

Leukemia & Lymphoma
E MontserratF Bosch

Abstract

Fludarabine produces high response rates in patients with B-cell chronic lymphocytic leukemia (CLL). Nevertheless, response to fludarabine of patients with previously treated CLL varies from 17% to 74% (0% to 38% CR). In 68 patients with heavily pretreated and advanced CLL, an overall response rate to fludarabine of 28% (4% CR) was observed. Response correlated with sensitivity of the disease to previous treatments (relapsing vs. refractory disease) (62% vs. 20%; p = 0.005) and, albeit not significantly, with the number of cycles of fludarabine (>3 vs. < or = 3) that patients could receive (36% vs. 15%; p = NS). Responding patients had a longer survival (median, not reached) than those not responding (median, 11 months) (p = 0.03). Severe toxicity was observed in some cases. It is concluded that fludarabine is a highly useful agent in CLL. However, in order to improve its effectiveness and decrease its toxicity, fludarabine should be given as soon as a lack of response to front-line therapy is observed and before the disease becomes completely resistant to therapy.

References

Jan 1, 1975·Acta Anaesthesiologica Scandinavica·A Gjedde, B Hindfelt
Feb 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BaroneA Grieco
Aug 1, 1988·Postgraduate Medical Journal·M LischnerM Shaklai
Jul 1, 1986·Journal of Clinical Pathology·T J HamblinB J Young
Mar 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Montserrat, C Rozman
Jan 1, 1993·Leukemia & Lymphoma·M J KeatingE Estey
Aug 1, 1993·European Journal of Haematology·P L ZinzaniF Zaja
Jan 1, 1961·British Journal of Haematology·D A GALTONJ V DACIE
Jan 1, 1991·Leukemia & Lymphoma· Spanish Cooperative Group Pethema
Jan 1, 1991·Leukemia & Lymphoma·M M HansenD Pedersen

❮ Previous
Next ❯

Citations

Jan 27, 2009·Current Treatment Options in Oncology·Tahamtan AhmadiEdward Stadtmauer
Sep 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mohamed L SorrorDavid G Maloney
Mar 25, 2000·Drugs & Aging·N Kalil, B D Cheson
Apr 17, 2004·British Journal of Haematology·D OscierUNKNOWN Guidelines Working Group of the UK CLL Forum. British Committee for Standards in Haematology
Oct 27, 2007·British Journal of Haematology·Rebecca L AuerFinbarr E Cotter
Jun 21, 2005·Blood Reviews·Farhad Ravandi, Susan O'Brien
May 8, 2008·Expert Review of Ophthalmology·Xiaoyan DingChi-Chao Chan
Jul 29, 2006·Expert Opinion on Pharmacotherapy·Thomas ElterAndreas Engert
Dec 11, 2002·British Journal of Haematology·Francesc BoschUNKNOWN GELCAB (Grup per l'Estudi dels Limfomes a Catalunya i Balears)
Aug 9, 2005·Hematology/oncology Clinics of North America·Silvia Montoto, T Andrew Lister
Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vicki A MorrisonCharles A Schiffer
Aug 31, 2002·Hematological Oncology·Gerassimos A PangalisMaria K Angelopoulou
Nov 28, 2001·Hematology·K R RaiE Montserrat
Oct 6, 2005·Blood·Emili MontserratFrancesc Bosch
Nov 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A BoogaertsM Klein
Dec 7, 2011·Cancer Control : Journal of the Moffitt Cancer Center·Marays Veliz, Javier Pinilla-Ibarz

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.